60 Degrees Pharmaceuticals (SCTP) Proxy filing summary

Executive summary

• The annual meeting will be held virtually on August 5, 2026, with voting available by telephone or mail for shareholders of record as of July 2, 2026.

• Proxy materials are distributed primarily via the internet to expedite delivery, reduce costs, and conserve resources.

• The Board recommends voting in favor of all proposals, including director elections, equity plan amendments, a reverse stock split, auditor ratification, a management success fee, and potential adjournment to solicit more proxies.

Voting matters and shareholder proposals

• Shareholders will vote on electing five directors, amending the 2022 Equity Incentive Plan to add 800,000 shares, a reverse stock split (1:5 to 1:10), ratifying RBSM LLP as auditor, approving a management success fee, and adjourning the meeting if needed.

• The Board recommends a "FOR" vote on all proposals.

• No other business is expected at the meeting, and no shareholder nominations were received.

Board of directors and corporate governance

• The Board consists of five directors, three of whom are independent under Nasdaq rules.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with written charters.

• The Board met six times in 2025, with high attendance and regular executive sessions for non-management directors.

• The Nominating and Corporate Governance Committee considers diversity and experience in director selection.

• Corporate governance materials, including the Code of Conduct, are available on the company website.